Bronchodilator reversibility in children with cystic fibrosis: prevalence and associated factors. Harvey A, Beydon N, Thouvenin G, Peulier-Maitre E, et al. Arch Pediatr 2026;33:105578.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harvey A, Beydon N, Thouvenin G, Peulier-Maitre E, et al. Bronchodilator reversibility in children with cystic fibrosis: prevalence and associated factors. Arch Pediatr 2026;33:105578.
PMID: 42497571